Altruistic Stem Cells and Cancer Stem Cells

Cancer Stem Cells

Volumn , Issue , 2014, Pages 89-105

  Das, Bikul ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Altruistic stem cell defense (ASD) system; Cancer stem cell (CSC) hypothesis; Cancer stem cells; Human embryonic stem cells (hESCs); Stemness reprogramming mechanism

Indexed keywords

CYTOLOGY; DISEASES; NETWORK SECURITY;

ALTRUISTIC STEM CELL DEFENSE SYSTEM; CANCER STEM CELL HYPOTHESIS; CANCER STEM CELLS; CELL/B.E; DEFENCE SYSTEMS; EMBRYONIC STEM CELLS; HUMAN EMBRYONIC STEM CELL; STEM-CELL; STEMNESS REPROGRAMMING MECHANISM;

STEM CELLS;

EID: 84926509795     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118356203.ch7     Document Type: Chapter

References (53)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100(7):3983-8.
2. Andreas W. (2007). Robustness and evolvability in living systems. Princeton University Press, NJ, page 277.
3. Andrews PW. (2002). From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci 357:405-417.
4. Bonnet D, Dick JE. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730-7.
5. Cai J, Weiss ML, Rao MS. (2004). In search of "stemness." Exp Hematol. 32:585-598.
6. Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. Oxidative stress, redox, and the tumor microenvironment. (2004). Semin Radiat Oncol 14(3):259-66.
7. Cottler-Fox MH, Lapidot T, Petit I, et al. (2003). Stem cell mobilization. Hematology Am Soc Hematol Educ Program 419-37.
8. Das B. (2000). Science Behind Squalene, Toronto Medical Publishing, Toronto, Canada. ISBN 1-890412-95-3. http://www.scienceforlife.eu/tekst%20sciencebehindsqualene.htm
9. Das B. (2007). The role of VEGF autocrine signaling in hypoxia and oxidative stress driven "stemness switch": implications in solid tumor progression and metastasis. PhD thesis: Institute of Medical Sciences, University of Toronto.
10. Das B, Bayat-Mokhtari R, Tsui M, Lotfi S, Tsuchida R, Felsher DW, Herman Yeger. (2012). HIF-2alpha suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells. Stem Cells 30 (8): 1685-95.
11. Das B, Tsuchida R, Baruchel S, Yeger H. (2005b). Idea and evidence of "tumor stemness switch." In: International Workshop on Cancer Stem Cell; November 10-12; Milan, Italy; p. 34.
12. Das B, Tsuchida R, Malkin D, Baruchel S, Yeger H. (2008). Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side-population fraction. Stem Cells 26 (7):1818-30.
13. Das B, Tsuchida R, et al. (2009). The idea and evidence for the tumor stemness switch. Book chapter in the Regulatory Networks in Stem Cells. Humana Press, NJ.
14. Das B, Yeger H, Tsuchida R, et al. (2005a). A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res 65:7267-7275.
15. Dick JE. (2003). Breast cancer stem cells revealed. Proc Natl Acad Sci USA 100(7):3547-9.
16. Draper JS, Smith K, Gokhale P, et al. (2004). Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22:53-54.
17. Durand R. (2001). Intermittent blood flow in solid tumors-an under-appreciated source of "drug-resistance." Cancer and Metastasis Reviews 20:57-61.
18. Fowler JF. (1991). Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment-continually rapid proliferation unmasked. Radiother Oncol 22(3):156-8.
19. Fuchs E, Tumbar T, Guasch G. (2004). Socializing with the neighbors: stem cells and their niche. Cell 116(6):769-78.
20. Furusawa C, Kaneko K. (2012). A dynamicalsystems view of stem cell biology. Science 338: 215-217.
21. Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, Yarnitzky T, et al. (2006). Oscillations and variability in the p53 system. Mol Syst Biol 2: 2006-2033.
22. Hill RP. (2006). Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66(4):18911896.
23. Hirschmann-Jax C, Foster AE, Wulf GG, et al. (2004). A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101(39):14228-33.
24. Ito K, Hirao A, Arai F, Matsuoka S et al. (2004). Regulation of oxidative stress by ATM is required for self-renewal of hematopoietic stem cells. Nature 431:997-1002.
25. Jogi A, Ora I, Nilsson H, et al. (2002). Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 99(10):7021-6.
26. Kim CF, Jackson EL, Woolfenden AE, et al. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6):823-35.
27. Kim JJ, Tannock IF. (2005). Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5(7):516-52.
28. Li L, Xie T. (2005). Stem cell niche: structure and function. Annu Rev Cell Dev Biol 21: 605-31.
29. Mackillop W, Ciampi A, Till J, Buick R. (1983). A stem cell model of human tumor growth: implications for tumor cell clonogenic assay. JNCI 70(1):9-16.
30. Maenhaut C, Dumont JE, Roger PP, van Staveren WCG. (2010). Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 31 (2): 149-158.
31. Mikkers H, Frisen J. (2005). Deconstructing stemness. Embo J. 24:2715-2719.
32. Nowell PC. (1986). Mechanisms of tumor progression. Cancer Res 46(5):2203-7.
33. Pan G, Thomson JA. (2007). Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17:42-49.
34. Pardal R, Clarke MF, Morrison SJ. (2003). Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3(12):895-902.
35. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. (2005). Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 65(14):6207-19.
36. Pai R, Jones MK, Tomikawa M, Tarnawski AS. (1999). Activation of Raf-1 during experimental gastric ulcer healing is Ras-mediated and protein kinase C-independent. Am J Pathol 155(5):1759-66.
37. Prockop DJ. (2009). Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther. 17:939-946.
38. Ramalho-Santos M, Yoon S, Matsuzaki Y, et al. (2002). "Stemness": transcriptional profiling of embryonic and adult stem cells. Science. 298:597-600.
39. Reya T, Morrison SJ, Clarke MF, Weissman IL. (2001). Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-11.
40. Rich JN. (2007). Cancer stem cells in radiation resistance. Cancer Res 67(19):8980-4.
41. Rinzel J, Terman D, Wang X, Ermentrout B. (1998). Propagating activity patterns in largescale inhibitory neuronal networks. Science. 279:1351-1355.
42. Silva J, Smith A. (2008). Capturing pluripotency. Cell. 132:532-536.
43. Singh AM, Hamazaki T, Hankowski KE, et al. (2007). A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells. 25:2534-2542.
44. Singh SK, Hawkins C, Clarke ID, et al. (2004). Identification of human brain tumour initiating cells. Nature 432(7015):396-401.
45. Suda T, Arai F, Shimmura S. (2005). Regulation of stem cells in the niche. Cornea 24(8 Suppl): S12-S7.
46. Trott KR. (1994). Tumour stem cells: the biological concept and its application in cancer treatment. Radiother Oncol 30(1):1-5.
47. Tscharntke M, Pofahl R, Krieg T, Haase I. (2005). Ras-induced spreading and wound closure in human epidermal keratinocytes. Faseb J 19 (13):1836-8.
48. Tsuchida R., Das B., Yeger H, et al. (2008). Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling Oncogene. Online issue, March 8. *Equal contribution 2007.
49. Turcotte M, Garcia-Ojalvo J, Suel GM. (2008). A genetic timer through noise-induced stabilization of an unstable state. Proc Natl Acad Sci USA. 105:15732-15737.
50. Tyson JJ. (1998). Another turn for p53. Molecular Systems Biology 2:2006.0032.
51. Wicha M, Liu S, Dontu G. (2006). Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66:1883-90.
52. Youk H and Qudenaarden VA. (2010). Microbiology: Altruistic defense. Nature. 467:34-35.
53. Zhao J, Yu H, Luo JH, Cao ZW, Li YX. (2006). Hierarchical modularity of nested bow-ties in metabolic networks. BMC Bioinformatics 7 (386):1-16.